fluorine F 18 sodium fluoride

RADIATION7 trials

Conditions

Bone CancerBone MetastasesHormone-Resistant Prostate CancerHormone-resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Prostate CarcinomaProstate CancerProstatic Neoplasms

Early Phase 1

Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer

CompletedNCT00956163

National Cancer Institute (NCI)Bone Metastases, Recurrent Prostate Cancer, Stage IIA Prostate Cancer +4

Start: 2010-03-31End: 2014-05-31Updated: 2014-07-02

Phase 1

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

TerminatedNCT02429804

Stanford UniversityHormone-Resistant Prostate Cancer, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate Carcinoma

Start: 2015-04-30End: 2017-05-15Updated: 2017-05-30

Phase 2

Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

CompletedNCT00936975

National Cancer Institute (NCI)Hormone-Resistant Prostate Cancer, Metastatic Malignant Neoplasm in the Bone, Recurrent Prostate Carcinoma +1

Start: 2009-09-30End: 2014-12-31Updated: 2015-07-16

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

TerminatedNCT01816048

University of Wisconsin, MadisonProstate Cancer, Prostatic Neoplasms

Start: 2013-05-31End: 2016-11-30Updated: 2019-12-09

Unknown Phase

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

TerminatedNCT01541358

Stanford UniversityBone Cancer

Start: 2012-05-31End: 2012-09-30Updated: 2017-06-14

Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

CompletedNCT01967862

City of Hope Medical CenterRecurrent Prostate Cancer

Start: 2013-12-31End: 2018-09-17Updated: 2020-09-17

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

WithdrawnNCT02169063

University of WashingtonHormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer